Skip to content
Search

Latest Stories

Stung by criticism, Boris Johnson says UK will 'massively increase' testing

Prime Minister Boris Johnson said Britain would "massively" increase testing amid a growing wave of criticism on Thursday (2) about his government's failure to provide widespread coronavirus screening.

In a video message posted online on Wednesday night from Downing Street, where he has been in self-isolation since announcing on March 27 that he had contracted the virus, Johnson said testing was the "way through".


"We're also massively increasing testing. As I have said for weeks and weeks this (testing) is the way through," Johnson said.

"This is how we will unlock the coronavirus puzzle, this is how we will defeat it in the end."

He was reacting to condemnation of his government, especially in the media, after officials revealed that just 2,000 out of half-a-million staff in the state-run National Health Service (NHS) had been tested.

There have also been reports of staff being turned away from drive-in test centres because they did not have the correct paperwork, or others which were deserted because testing was by appointment only.

Figures published Wednesday showed a total of 2,352 people with COVID-19 have died in the UK, an increase of 563, the largest single-day rise. Two of the deaths were medics.

Testing for the general public has also been condemned as not being widespread enough.

On Tuesday, 10,000 hospital patients and NHS staff were tested in England, well below the daily target of 25,000 and the 70,000 a day achieved in Germany.

Various normally pro-government newspapers condemned the plans as "chaotic", a "scandal" and a "shambles" as the backlash gathered pace.

Paul Nurse, chief executive of biomedical research centre the Francis Crick Institute, told the BBC that the government should summon "the Dunkirk spirit" and let 'small ship' labs start screening for the killer disease.

So far, Public Health England (PHE), the body tasked with testing, has insisted all screening should be carried out centrally.

PHE medical director Professor Paul Cosford defended his organisation's work.

"At the very outset we identified this, we got the tests in place, we designed the tests in our laboratories. We have played our part," he told BBC radio.

Britain is currently in lockdown, with shops shut and the public asked to stay at home to try to limit the spread of coronavirus.

The government has promised an enormous package of support for businesses and employees hit by the measures, but is facing questions about how quickly the money is getting through.

New government figures show 950,000 people applied for state welfare support known as universal credit in the last fortnight.

It is available to the unemployed and those on low incomes.

More For You

Prada 2026 sandals

Prada acknowledges Indian influence behind its Spring Summer 2026 men’s footwear

Instagram/prada/iStock

Prada finally acknowledges Kolhapuri chappals inspired 2026 sandals after Indian backlash over Milan show

Quick highlights:

• Prada confirms Indian roots behind 2026 ‘leather sandals’ after controversy
• Indian artisans and officials accused the brand of cultural appropriation
• The footwear resembles traditional Kolhapuri chappals with GI status
• Prada says designs are still in development and open to dialogue with India

Keep ReadingShow less
Anna Wintour

Wintour’s style of leadership earned her the nickname “Nuclear Wintour”

Getty Images

Anna Wintour steps down as editor of US Vogue after 37 years

Key points

  • Anna Wintour steps down as editor of US Vogue after 37 years
  • She will remain Vogue’s global editorial director and hold senior roles at Condé Nast
  • Wintour transformed US Vogue into a global fashion authority
  • The 75-year-old has received numerous honours, including the Presidential Medal of Freedom

End of an era at US Vogue

Anna Wintour has stepped down as the editor of US Vogue, bringing to a close a 37-year tenure that redefined the publication and saw her become one of the most influential figures in global fashion.

The announcement was made on Thursday (26 June) during a staff meeting in New York. Wintour, 75, will no longer oversee the day-to-day editorial operations of Vogue’s US edition. However, she will continue to serve as Vogue’s global editorial director and Condé Nast’s chief content officer, maintaining senior leadership roles across the company.

Keep ReadingShow less
Nadiya Hussain

She also reassured her followers that “exciting” new projects are on the way

Getty Images

“I won’t always be grateful” says Nadiya Hussain after BBC axes her cookery show

Key points

  • Nadiya Hussain confirms BBC will not renew her cookery series
  • Bake Off winner challenges expectations to remain “grateful”
  • She says hard work and talent, not luck, brought her success
  • Celebrities, including Annie Lennox and Fearne Cotton, show support

BBC ends decade-long collaboration with Bake Off star

Nadiya Hussain has spoken out after the BBC decided not to commission another cookery programme with her. The popular TV chef, who won The Great British Bake Off in 2015, shared her views on social media, stating that she “won’t always be grateful” and should not be expected to remain silent about career setbacks.

The decision ends a nearly 10-year working relationship between the broadcaster and Hussain, who has hosted several well-received cookery shows under the BBC banner. In her latest Instagram video, she addressed the public’s reaction and emphasised her right to expect more from her career.

Keep ReadingShow less
weight loss injections UK

The importance of vigilance as demand for these weight loss and diabetes drugs continues to grow

iStock

Hundreds report pancreas issues linked to weight loss injections as UK launches safety study

Key points

  • Almost 400 reports of acute pancreatitis linked to weight loss and diabetes jabs have been filed in the UK
  • Most cases involve popular GLP-1 drugs including Ozempic, Wegovy, and Mounjaro
  • Health officials are investigating possible genetic causes behind the side-effects
  • Patients hospitalised with pancreatitis encouraged to report symptoms via MHRA’s Yellow Card scheme
  • Adverse drug reactions cost the NHS an estimated £2.2bn annually

Health watchdog investigates spike in serious side-effects from GLP-1 drugs

UK health authorities have launched a study into the side effects of popular weight loss and diabetes drugs following a spike in reported cases of acute pancreatitis. Nearly 400 reports have been received via the Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, which monitors side effects and adverse reactions related to medicines and medical devices.

The medicines involved are GLP-1 receptor agonists – including semaglutide (marketed as Ozempic and Wegovy), liraglutide, and tirzepatide (branded as Mounjaro). The Yellow Card data shows that 181 of the cases involved tirzepatide alone.

Keep ReadingShow less
M&S launches strawberries

M&S’s latest offering taps into both tradition and innovation

The Wire

M&S launches strawberries and cream sandwich ahead of Wimbledon

Summary

  • M&S unveils limited edition strawberries and cream sandwich for £2.80
  • Inspired by Japanese 'sweet sandos', it features Red Diamond strawberries and whipped cream cheese
  • Available in stores now, found in the savoury sandwich aisle
  • Launch coincides with Wimbledon and British strawberry season
  • Wimbledon increases strawberries and cream price for first time in 15 years

New summer sandwich from M&S

Marks & Spencer has launched a limited edition M&S strawberry sandwich, combining classic British summer flavours with a Japanese twist. Priced at £2.80, the strawberries and cream sandwich is available in M&S stores now.

The dessert-style sandwich features M&S’s exclusive Red Diamond strawberries, whipped cream cheese, and sweetened bread. Despite its sweet contents, the product is found in the savoury sandwich section of M&S Food halls.

Keep ReadingShow less